Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 2/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | PELI1 | Q96FA3 | 1/20 | 0.38 |
| ▸ | DAPK1 | P53355 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30633654 | 1.00 | BACE1 (0.45) | BACE1ALOX5ALDH1A1HPGDHSD17B10 | |
| SCHEMBL28020176 | 0.87 | HDAC4 (0.46) | BACE1ALOX5ALDH1A1HPGDHSD17B10 | |
| SCHEMBL4163081 | 0.87 | BACE1 (0.43) | BACE1ALOX5ALDH1A1HPGDHSD17B10 | |
| SCHEMBL29700247 | 0.85 | ALDH1A1 (0.54) | BACE1ALOX5ALDH1A1HPGDHSD17B10 | |
| SCHEMBL3042569 | 0.85 | ALDH1A1 (0.54) | BACE1ALOX5ALDH1A1HPGDHSD17B10 | |
| SCHEMBL28614880 | 0.82 | TSHR (0.41) | BACE1ALOX5ALDH1A1HPGDHSD17B10 | |
| Formaldehyde SCHEMBL5123936 | 0.81 | ALDH1A1 (0.50) | BACE1ALOX5ALDH1A1HPGDHSD17B10 | |
| SCHEMBL21794264 | 0.79 | TSHR (0.46) | BACE1ALDH1A1HPGDHSD17B10BCL2L1 | |
| SCHEMBL3185678 | 0.79 | PTGS2 (0.39) | BCL2L1SMN1; SMN2TSHRMEN1MAPT | |
| SCHEMBL21794267 | 0.78 | TSHR (0.41) | BACE1ALOX5ALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020068665-A1 | USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN | FABIUS BIOTECHNOLOGY (US) | 2020-04-02 | — | — | WO | claimed |
| EP-2916814-A1 | COMPOSITION CONTAINING A CELLULOSE DERIVED CAPSULE WITH A SUNSCREEN | Colabs International Corporation (US) | 2015-09-16 | — | — | EP | claimed |
| WO-2014074555-A1 | COMPOSITION CONTAINING A CELLULOSE DERIVED CAPSULE WITH A SUNSCREEN | CoLabs International Corporation (US) | 2014-05-15 | — | — | WO | claimed |
| US-20140127275-A1 | Composition Containing a Cellulose Derived Capsule With A Sunscreen | CoLabs International Corporation (US) | 2014-05-08 | — | — | US | claimed |
| EP-2367852-A1 | COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS | Sederma (FR) | 2011-09-28 | — | — | EP | claimed |
| US-20110008272-A1 | Use of Creatine or Creatine Compounds for Skin Preservation | AVICENA GROUP, INC. (US) | 2011-01-13 | — | — | US | claimed |
| WO-2010067327-A1 | COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS | SEDERMA (FR) | 2010-06-17 | — | — | WO | claimed |
| WO-2010044076-A2 | COSMETIC AND TOPICAL USE OF XANTHOHUMOL INCLUDING BRIGHTENING SKIN COMPLEXION AND REDUCING CUTANEOUS REDNESS | SEDERMA (FR) | 2010-04-22 | — | — | WO | claimed |
| EP-1924254-A2 | USE OF TELLURIUM COMPOUNDS FOR PROTECTION FROM ULTRA-VIOLET RADIATION | Biomas Ltd. (IL) | 2008-05-28 | — | — | EP | claimed |
| WO-2007032010-A2 | USE OF TELLURIUM COMPOUNDS FOR PROTECTION FROM ULTRA-VIOLET RADIATION | BIOMAS LTD. (IL) | 2007-03-22 | — | — | WO | claimed |
| US-20060193789-A1 | Surfacant, film forming agent, water, gas propellant; plant and animal extracts and oils; may include malathion | FOAMIX LTD. (IL) | 2006-08-31 | — | — | US | claimed |
| EP-1495103-A4 | TARGETED CONTROLLED DELIVERY COMPOSITIONS ACTIVATED BY CHANGES IN PH OR SALT CONCENTRATION | SALVONA LLC (US) | 2006-03-22 | — | — | EP | claimed |
| US-20050186158-A1 | Use of creatine or creatine compounds for skin preservation | AVICENA GROUP, INC. (US) | 2005-08-25 | — | — | US | claimed |
| US-6897281-B2 | Breathable polyurethanes, blends, and articles | NOVEON IP HOLDINGS CORP. (US) | 2005-05-24 | — | — | US | claimed |
| EP-1495103-A1 | TARGETED CONTROLLED DELIVERY COMPOSITIONS ACTIVATED BY CHANGES IN PH OR SALT CONCENTRATION | Salvona L.L.C. (US) | 2005-01-12 | — | — | EP | claimed |
| WO-2003087287-A1 | TARGETED CONTROLLED DELIVERY COMPOSITIONS ACTIVATED BY CHANGES IN PH OR SALT CONCENTRATION | SALVONA L.L.C. (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030195133-A1 | Targeted controlled delivery compositions activated by changes in pH or salt concentration | SALVONA L.L.C. | 2003-10-16 | — | — | US | claimed |
| US-5837697-A | CONTAINING SALICYLIC ACID, SUNSCREEN AGENT AND A CARRIER | THE PROCTER & GAMBLE COMPANY (US) | 1998-11-17 | — | — | US | claimed |
| US-11957769-B2 | Polyhydroxy fullerene sunscreen active agents and compositions | THE CLEVELAND CLINIC FOUNDATION (US) | 2024-04-16 | — | — | US | disclosed |
| US-4098881-A | COMPOSITIONS TO CONTROL THE CHRONIC EFFECTS OF EXPOSURE TO SUNLIGHT COMPRISING CONJUGATED DIENES | THE PROCTER & GAMBLE COMPANY (US) | 1978-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110008272-A1 | Use of Creatine or Creatine Compounds for Skin Preservation | PC, CKMT1A; CKMT1B, CHEK1 | BACE1 2648/4885ALOX5 3715/4885ALDH1A1 2904/4885 |
| US-20030195133-A1 | Targeted controlled delivery compositions activated by changes in pH or salt concentration | TRPC5, TRPV1, TRPV2 | BACE1 812/4885ALOX5 1690/4885ALDH1A1 2305/4885 |
| US-20140127275-A1 | Composition Containing a Cellulose Derived Capsule With A Sunscreen | MSH6, TYR, CUTA | BACE1 1198/4885ALOX5 856/4885ALDH1A1 854/4885 |
| US-20050186158-A1 | Use of creatine or creatine compounds for skin preservation | PC, CKMT1A; CKMT1B, CHEK1 | BACE1 2648/4885ALOX5 3715/4885ALDH1A1 2904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.